American Journal on Addictions

Papers
(The median citation count of American Journal on Addictions is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Issue Information41
AAAP's Annual Meeting and Scientific Symposium33
Stand against stigma31
AAAP 36th Annual Meeting & Scientific Symposium Save the Date28
Call for Special Issue 202426
Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada24
AAAP Stimulant Use Disorder PIP24
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances24
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression20
A scoping review of sensory‐based interventions to address alcohol consumption20
2024 Annual Meeting Posters19
Longitudinal pathway from low academic performance in adolescence to prescription drug misuse in adulthood: The mediating role of substance use and the moderating role of sex16
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort15
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey15
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment14
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States14
Gender differences in circumstances associated with cannabis use13
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–202112
2025 AAAP Case Conference12
Call for Special Issue Papers 202512
Become a member of AAAP!12
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada12
Call for Review Papers 202411
Narcotics Anonymous members in recovery from methamphetamine use disorder11
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia11
AM Registration Flyer11
Synthetic cannabinoid use and the acquired preparedness model11
Tobacco use and impulsivity in people with mental illness: A systematic review10
Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications—a systematic review10
Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms10
Correlates of optimism among patients in substance use disorder inpatient treatment9
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP9
Call for Review Papers 20248
Issue Information ‐ ToC8
Call for Special Issue Papers 20248
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?8
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study8
Emotional regulation in Gaming Disorder: A systematic review8
Preconference On‐Demand availability8
PCSS‐MOUD AND ORN: Find out more about AAAP's national grant initiatives8
Wanted: SPC Members: Join AAAP's Scientific Program Committee (SPC) and shape the future of the Academy7
Call for review papers 20227
Issue Information7
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population7
Issue Information ‐ Editorial Board7
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP7
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications7
AJA Annual Meeting 20236
AAAP AATT Preconference6
Call for Review Papers 20256
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates6
Extended‐release buprenorphine in pregnancy6
AAAP Podcast EP6
AAAP Call for Abstracts6
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!5
Stand Against Stigma5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us5
Call for Special Issue Papers 20255
Issue Information ‐ ToC5
BREAKING NEWS: AAAP Earns a Spot in ACCME's Innovation Partner Circle!5
Personality predicting relapse: A facet analysis of the NEO PI‐R5
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)5
Issue Information5
Issue Information ‐ Editorial Board5
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study5
AAAP's Performance in practice activities5
2023 Advanced Addiction Psychopharmacology Course5
Call for Special Issue 20234
Shining a light on alcohol use disorder through the eyes of the patient: Improving recognition and management4
Health care service utilization and drug overdose death: A national nested case–control registry study4
Addiction specialists' attitudes toward psychedelics: A National Survey4
2023 Addictions and Their Treatment Course4
Cannabis Use Disorders Performance in Practice4
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs4
Call for Symposium Abstracts4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States4
Psychedelic‐assisted therapy for substance use disorders: Between urgency and uncertainty4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study4
Call for special issue 20234
4
Association between experiencing gambling problems and adverse behavioral health outcomes among U.S. military service members, 20183
Stand Against Stigma3
2021 AJA Reviewer List3
Mini‐Symposia I3
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem3
AAAP 2024 Self‐Assessment Exam Now Available3
Call for Review Papers 20263
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting3
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!3
Issue Information ‐ Editorial Board3
Save the Date ‐ Annual Meeting 20253
3
Treating beyond the city limits: Building capacity in all communities3
AAAP NEWSLETTER: What do your colleagues have to say about the latest updates in Addiction Psychiatry?3
AJA AM Save the Date 20233
AJA AM save the date 20233
Medical Update3
Addiction Psychiatry Advanced Psychotherapy Curriculum2
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort2
Become an AAAP Member2
Call for Review Papers 20262
36th AAAP Annual Meeting and Scientific Symposium Recap2
Issue Information ‐ Editorial Board2
2025 Call for Symposium Abstracts2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study2
2
Gambling, tobacco use, and health among individuals in substance use disorder treatment2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series2
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem2
Call for Review Papers 20232
Medication Management for Stimulant Use Disorder Webinar2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders2
Trends in substance use disorder diagnoses among Veterans, 2009–20192
FREE WEBINAR: Master MI Techniques with Dr. Brian Borsari, September 10, 20252
Psychotherapy Webinar Series AJA2
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth2
Concurrent Paper Sessions2
Paper sessions2
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use1
Mini‐Symposia II1
Call for special issue 20231
2024 Annual Meeting Posters1
2023 Advanced Addiction Psychopharmacology Course1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study1
Cannabis Use PIP Ad1
Session name: Medical update1
Call for Special Issue Papers 20261
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients1
Call for Special Issue Papers 20261
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 20241
Program title youth substance use and addiction timely updates on a critical issue1
AJA Annual Meeting 20241
Examining family member characteristics by treatment status of the relative with substance use problems1
Nicotine use and patient‐directed discharge rate in psychiatric inpatients: A retrospective cohort1
Call for special issue 20231
Conference Schedule1
Addiction Psychiatry Advanced Psychotherapy Curriculum1
Symposium III1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?1
Daily cannabis use may cause cannabis‐induced hyperalgesia1
PCSS exchange AJA Ad1
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic1
Opioid Recover Network ‐ ORN: Recruiting qualified consultants for the ORN1
AAAP Membership1
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam1
33rd AAAP Annual Meeting and Scientific Symposium Recap1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization1
Cannabis and the overdose crisis among US adolescents1
AJA Psychedelics1
Issue Information1
Film & Media Workshop1
Opioid use disorder in the active service: Implications for intervention1
Symposium I1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics1
The mediating role of impulsivity in the relationship between childhood maltreatment and depression in methamphetamine patients1
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review1
Call for special issue 20231
2025 Combined Poster File1
NEW BUNDLED COURSES: Save big on these bundled courses as you prepare for the boards1
32nd AAAP Annual meeting & scientific symposium recap1
NEW BUNDLED COURSES: Save big on these bundled courses as you prepare for the boards0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood0
Imposter syndrome and college students' drinking behaviors: The roles of negative affect and coping motivated alcohol use0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 20240
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths0
Issue Information0
Call for Special Issue 20220
Issue Information0
Film & Media Workshop0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder0
AAAP_Call for Review papers‐20240
2023 Reviewer List (n = 223)0
Trends in racial/ethnic and geographic disparities in substance use disorders mortality in the United States, 2000–20190
Issue Information0
Call for review papers 20220
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study0
2024 Reviewer List0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)0
Estimating the effects of prenatal cannabis exposure on birth outcomes0
Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study0
Call for Review Papers 20250
Medical marijuana access and prolonged opioid use among adolescents and young adults0
FREE Training & Mentoring: PCSS and ORN0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?0
AAAP Performance and Practice (PIP) Resources0
High‐intensity transcranial alternating current stimulation for gambling disorder comorbidities with alcohol use disorders: A case report0
Differential mortality among US veterans: Social determinants of health, substance use disorder, and substance use treatment0
AAAP PIPS 20230
FREE WEBINAR: Cultural Considerations in Tribal Behavioral Health Practice, December 10, 20250
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial0
Reasons for electronic cigarette use: Differences based on sex and young adult status0
AAAP's Educational Offerings0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US0
AJA psychedelic Ad0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?0
Become A AAAP Member!0
CSAM‐SMCA 2022 Scientific conference and annual meeting0
Become a AAAP Member0
Issue Information0
Response to commentary, from Bisol et al., on “Tobacco use and impulsivity in people with mental illness: A systematic review,Praecht, A. et al. (2025). Am. J. Addict. 34–4: 383–4030
Motivational Interviewing PIP0
Associations between big five personality dimensions and lifetime use of cannabis0
AAAP Travel Awards Open0
AAAP Podcast Addiction & Zyn Tackling Tobacco and Nicotine Use Disorder in 20250
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients0
Issue Information0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance0
Managing Opioid Use Disorder Care in the Era of Fentanyl0
Psychotherapy Webinar Series AJA0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey0
Response to Costa et al.: Caution is warranted when comparing estimates from differently defined study samples0
Symposium IV0
Issue Information0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder0
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam0
Motivational Interviewing Performance in Practice0
Double trouble ‐ Examining the co‐occurrence of compulsive sexual behavior disorder and gambling disorder among two American samples0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20190
Absorption of naloxone in patients prescribed buprenorphine‐naloxone0
Conference Schedule0
AAAP podcast0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder0
Travel Award AJA0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use0
Become a AAAP Member0
Sex, gambling, and social media: Update on treatment and research of behavioral addictions0
Addictions and their treatment0
Call for Review Papers 20240
Symposium IV0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study0
0
Symposia, Medical Update, and Case Conference0
AAAP Psychotherapy Curriculum Series0
Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam0
AAAP Podcast0
Identifying treatment responders to the combination of varenicline and naltrexone0
Medication treatment for alcohol use disorder in special populations0
Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate0
Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate0
0.3129460811615